Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based

Sanjeev K Sharma1, Jitender S Makkar1, Ajeet Bana2

  • 1Departments of Cardiology, Eternal Heart Care Centre & Research Institute, Jaipur, 302017, India.

Indian Heart Journal
|August 22, 2022
PubMed

Insights

Premature coronary artery disease (CAD) affects a third of Indian patients undergoing intervention. High cholesterol and tobacco use are key risk factors, with STEMI presentation more common in men.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Premature coronary artery disease (CAD) is a significant health concern in India.
  • Understanding its risk factors and presentation is crucial for targeted interventions.

Purpose of the Study:

  • To identify risk factors, clinical presentation, angiographic findings, and interventions in premature CAD.
  • To analyze differences between premature, very premature, and non-premature CAD in an Indian population.

Main Methods:

  • A study enrolled patients undergoing percutaneous intervention (PCI) between January 2018 and June 2021.
  • Premature CAD was defined by age: women 45-59 years, men 40-54 years; very premature: women <45 years, men <40 years.
  • Descriptive statistics and univariate odds ratios were calculated to compare groups.

Main Results:

  • 1238 (26.5%) patients had premature CAD, and 212 (4.5%) had very premature CAD.
  • Higher total cholesterol and non-HDL cholesterol were significant risk factors for premature CAD in both sexes.
  • Tobacco use was a notable risk factor in men, and STEMI presentation was more frequent in men with premature and very premature CAD.

Conclusions:

  • A third of Indian patients undergoing coronary intervention present with premature CAD.
  • Elevated total and non-HDL cholesterol, along with tobacco use (in men), are key risk factors.
  • The severity, indicated by STEMI presentation and similar extent/type of disease to non-premature CAD, highlights the aggressive nature of premature CAD.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
27
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22